BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30013021)

  • 41. Risk factors of early liver dysfunction after liver transplantation using grafts from donation after citizen death donors.
    He YB; Sun JS; Wang ZP; Yao G; Bai L; Li T; Zhao JM
    Transpl Immunol; 2022 Apr; 71():101525. PubMed ID: 34990790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Deschênes M; Belle SH; Krom RA; Zetterman RK; Lake JR
    Transplantation; 1998 Aug; 66(3):302-10. PubMed ID: 9721797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome.
    Botha JF; Langnas AN; Campos BD; Grant WJ; Freise CE; Ascher NL; Mercer DF; Roberts JP
    Liver Transpl; 2010 May; 16(5):649-57. PubMed ID: 20440774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Model for Early Allograft Function" Outperforms "Early Allograft Dysfunction" as a Predictor of Transplant Survival.
    Jochmans I; Fieuws S; Monbaliu D; Pirenne J
    Transplantation; 2017 Aug; 101(8):e258-e264. PubMed ID: 28557956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of portal venous velocity and portal venous flow with short-term graft regeneration in recipients of living donor liver transplants.
    Park MY; Lee YJ; Rha SE; Oh SN; Byun JY; Kim DG
    Transplant Proc; 2008 Jun; 40(5):1488-91. PubMed ID: 18589135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility of reduced-size orthotopic liver transplantation with fatty grafts and its potential regeneration in rats.
    Sheng Y; Jiahong D; Benli H
    Arch Med Res; 2009 Apr; 40(3):146-55. PubMed ID: 19427964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of serum cytokines in the development of early allograft dysfunction in living donor liver transplantation.
    Chae MS; Kim JW; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    Medicine (Baltimore); 2018 Apr; 97(16):e0400. PubMed ID: 29668595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation.
    Cho JY; Suh KS; Kwon CH; Yi NJ; Cho SY; Jang JJ; Kim SH; Lee KU
    Liver Transpl; 2005 Feb; 11(2):210-7. PubMed ID: 15666394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regeneration and function of hemiliver graft: right versus left.
    Akamatsu N; Sugawara Y; Tamura S; Imamura H; Kokudo N; Makuuchi M
    Surgery; 2006 Jun; 139(6):765-72. PubMed ID: 16782431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum interleukin-6 and tumor necrosis factor-α are associated with early graft regeneration after living donor liver transplantation.
    Chae MS; Moon KU; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    PLoS One; 2018; 13(4):e0195262. PubMed ID: 29649247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.
    Martini S; Tandoi F; Terzi di Bergamo L; Strona S; Lavezzo B; Sacco M; Maione F; Gonella F; Strignano P; Dell Olio D; Salizzoni M; Saracco GM; Romagnoli R
    Liver Transpl; 2017 Jul; 23(7):915-924. PubMed ID: 28422425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver Transplantation and Donor Body Mass Index >30: Use or Refuse?
    Andert A; Becker N; Ulmer F; Schöning W; Hein M; Rimek A; Neumann U; Schmeding M
    Ann Transplant; 2016 Mar; 21():185-93. PubMed ID: 27029495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive model and risk factors associated with a revised definition of early allograft dysfunction in liver transplant recipients.
    Nicolau-Raducu R; Cohen AJ; Bokhari A; Bohorquez H; Bruce D; Carmody I; Bugeaud E; Seal J; Sonnier D; Nossaman B; Loss G
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28856732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of liver graft function and regeneration by galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy in adult living-donor liver transplantation.
    Iida T; Isaji S; Yagi S; Hori T; Taniguchi K; Ohsawa I; Mizuno S; Usui M; Sakurai H; Yamagiwa K; Yamakado K; Uemoto S
    Clin Transplant; 2009; 23(2):271-7. PubMed ID: 19191810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of lactate clearance for the development of early allograft dysfunction and short-term prognosis in deceased donor liver transplantation.
    Kim DG; Lee JY; Jung YB; Song SH; Lee JG; Han DH; Joo DJ; Ju MK; Choi GH; Choi JS; Kim MS; Kim SI
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 29032588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Remnant liver regeneration and spleen volume changes after living liver donation: influence of the middle hepatic vein.
    Chen TY; Chen CL; Huang TL; Tsang LL; Wang CC; Wang SH; Yang CH; Concejero AM; Cheng YF
    Clin Transplant; 2006; 20(6):725-31. PubMed ID: 17100722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Volumetry-based selection of right posterior sector grafts for adult living donor liver transplantation.
    Kim BW; Xu W; Wang HJ; Park YK; Lee K; Kim MW
    Liver Transpl; 2011 Sep; 17(9):1046-58. PubMed ID: 21594965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
    Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
    Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.
    Olthoff KM; Kulik L; Samstein B; Kaminski M; Abecassis M; Emond J; Shaked A; Christie JD
    Liver Transpl; 2010 Aug; 16(8):943-9. PubMed ID: 20677285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.